Read + Share
Amedeo Smart
Independent Medical Education
Nobili A, D'Amelio M. Reconsidering dopaminergic modulation in Alzheimer's disease: A case for levodopa/carbidopa as a disease-modifying agent. Alzheimers Dement 2025;21:e70532.PMID: 40696850
Email
LinkedIn
Privacy Policy